Elanco Animal Health Incorporated
ELAN
$21.43
-$0.29-1.34%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 19.84% | 0.62% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 19.84% | 0.62% | |||
| Cost of Revenue | 5.59% | 4.72% | |||
| Gross Profit | 33.28% | -2.97% | |||
| SG&A Expenses | 15.11% | -5.70% | |||
| Depreciation & Amortization | -0.72% | -0.71% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 7.51% | 0.72% | |||
| Operating Income | 550.00% | -3.70% | |||
| Income Before Tax | 133.59% | -418.00% | |||
| Income Tax Expenses | 76.47% | 206.25% | |||
| Earnings from Continuing Operations | 120.65% | -711.76% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 120.65% | -711.76% | |||
| EBIT | 550.00% | -3.70% | |||
| EBITDA | 72.68% | -0.51% | |||
| EPS Basic | 120.62% | -711.99% | |||
| Normalized Basic EPS | 378.06% | -47.62% | |||
| EPS Diluted | 119.63% | -700.43% | |||
| Normalized Diluted EPS | 373.55% | -47.62% | |||
| Average Basic Shares Outstanding | 0.16% | 0.02% | |||
| Average Diluted Shares Outstanding | 1.83% | 0.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||